Mayne Pharma

Adelaide, Australia Founded: 1845 • Age: 181 yrs Acquired By Cosette Pharmaceuticals
Drug delivery systems are developed and marketed globally through partnerships.
Request Access

About Mayne Pharma

Mayne Pharma is a company based in Adelaide (Australia) founded in 1845 was acquired by Cosette Pharmaceuticals in February 2025.. Mayne Pharma has completed 1 acquisition, including Metrics Inc. Mayne Pharma offers products and services including Branded and Generic Drugs and Contract Services.

  • Headquarter Adelaide, Australia
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Mayne Pharma Group Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $269.66 M (USD)
    5.07
    as on Jun 30, 2025
  • Net Profit
    $-62.01 M (USD)
    46.14
    as on Jun 30, 2025
  • EBITDA
    $30.1 M (USD)
    585.71
    as on Jun 30, 2025
  • Latest Funding Round
    $3.4 M (USD), Grant

    May 09, 2022

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Cosette Pharmaceuticals

    & 2 more

    (Feb 20, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Mayne Pharma

Mayne Pharma is a publicly listed company on the ASX with ticker symbol MYX in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: ASX · Ticker: MYX . Sector: Health technology · Australia

Products & Services of Mayne Pharma

Mayne Pharma offers a comprehensive portfolio of products and services, including Branded and Generic Drugs and Contract Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Drugs in women's health and dermatology are developed and commercialized by Mayne Pharma to provide safer and more accessible medicines

Pharmaceutical development, analytical testing, and commercial manufacturing for oral and topical dose forms are provided by Mayne Pharma to clients worldwide

People of Mayne Pharma
Headcount 500-1000
Employee Profiles 50
Board Members and Advisors 7
Employee Profiles
People
Andrea Blank
Head Of Commercial, Mayne Pharma Australia
People
Gracen Adams
Senior Analyst, Pricing And Contracts
People
Daniel Moore
EVP, Specialty Products & Patient Solutions
People
Rick Ludwico
Major Account Executive - Market Access

Unlock access to complete

Board Members and Advisors
people
Ann Custin
Non-Executive Director
people
Carolyn Myers
Non-Executive Director
people
Frank Condella
Chair
people
Bruce Robinson
Non-Executive Director

Unlock access to complete

Funding Insights of Mayne Pharma

  • Total Funding
  • Total Rounds 5
  • Last Round Grant — $3.4M
  • First Round

    (12 Oct 2012)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2022 Amount Grant - Mayne Pharma Valuation

investors

Jun, 2015 Amount Debt – Conventional - Mayne Pharma Valuation

investors

Feb, 2015 Amount Post-IPO - Mayne Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Mayne Pharma

Mayne Pharma has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Dr. Reddy's Laboratories, Hospira and Cosette Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government department focused on industry, science, and resource development in Australia.
Founded Year Domain Location
Innovative medicines are developed and manufactured globally by the company.
Founded Year Domain Location
Diversified generic drugs are manufactured by Cosette Pharmaceuticals.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Mayne Pharma

Mayne Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Metrics Inc. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
CDMO specializing in oral and topical dosage forms and potent products
1994
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Mayne Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mayne Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Mayne Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mayne Pharma

Frequently Asked Questions about Mayne Pharma

When was Mayne Pharma founded?

Mayne Pharma was founded in 1845 and raised its 1st funding round 167 years after it was founded.

Where is Mayne Pharma located?

Mayne Pharma is headquartered in Adelaide, Australia. It is registered at Adelaide, South Australia, Australia.

What is the annual revenue of Mayne Pharma?

Annual revenue of Mayne Pharma is $269.66M as on Jun 30, 2025.

What does Mayne Pharma do?

Mayne Pharma was founded in 1845 in Adelaide, Australia, and operates in the pharmaceutical sector. Drug delivery systems are developed by the company, with numerous products launched and marketed via partnerships with licensees across multiple countries worldwide. Operations focus on pharmaceutical development and international distribution, supporting a range of therapeutic areas through established global collaborations.

What products or services does Mayne Pharma offer?

Mayne Pharma offers Branded and Generic Drugs and Contract Services.

Is Mayne Pharma publicly traded?

Yes, Mayne Pharma is publicly traded on ASX under the ticker symbol MYX.

How many acquisitions has Mayne Pharma made?

Mayne Pharma has made 1 acquisition, including Metrics Inc.

Who are Mayne Pharma's investors?
What is Mayne Pharma's ticker symbol?

The ticker symbol of Mayne Pharma is MYX on ASX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available